Seishi Tanaka
Kanazawa University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Seishi Tanaka.
Analyst | 2003
Reiko Iio; Satoshi Chinaka; Seishi Tanaka; Nariaki Takayama; Kazuichi Hayakawa
A capillary electrophoresis-mass spectrometry method for the simultaneous chiral determination of enantiomers of methamphetamine (MA), amphetamine (AP), dimethylamphetamine (DMA) and p-hydroxymethamphetamine (pOHMA), in urine has been developed. The internal standards used were 2-phenylethylamine and 1-amino4-phenylbutane. The electrolyte was 1 M formic acid (pH 2.2). The chiral selector, which was added to the electrolyte, was a mixture of 3 mM beta-cyclodextrin and 10 mM heptakis(2,6-di-O-methyl)-beta-cyclodextrin. The detection limits were 0.03 microg ml(-1) for the enantiomers of MA and AP and 0.05 microg ml(-1) for the enantiomers of pOHMA using selected ion monitoring. In the analysis of healthy adult urine samples spiked with MA, AP and pOHMA, the precision of within-run assays (n = 4) for the migration time after correction with two internal standards were under 0.04%, and the detection yields utilizing solid phase extraction were 95-105%. This method was applicable to the analysis of urine samples of MA addicts and DMA addicts.
Journal of Chromatography B: Biomedical Sciences and Applications | 2000
Satoshi Chinaka; Seishi Tanaka; Nariaki Takayama; Kiyonobu Komai; Tohru Ohshima; Kazumasa Ueda
A capillary electrophoretic method for the simultaneous chiral analysis of nine cationic drugs (18 enantiomers) has been developed. These drugs are methamphetamine (MA), amphetamine, dimethylamphetamine, ephedrine (EP), norephedrine, methylephedrine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxy-N-ethylamphetamine. The chiral selector, which was added to the electrolyte, was a mixture of beta-cyclodextrin and heptakis(2,6-di-O-methyl)-beta-cyclodextrin. The detection limits of all enantiomers were 0.1 microg/ml, and the intermediate precisions of migration time and peak area of within-run assays (n=6) were under 0.3% and 1.4%, respectively. The calibration curves of the peak area of (1R,2S)-(-)-EP and S-(+)-MA were linear in the range 0.2-500 microg/ml. This method was applicable to urine analysis.
Biomedical Chromatography | 1997
Nariaki Takayama; Seishi Tanaka; Kazuichi Hayakawa
Stimulants that are controlled by the Stimulant Drug Control Law of Japan are methamphetamine (MA) and amphetamine (AP). MA is used by most stimulant addicts, and AP is detected as its main metabolite. We have developed a high-performance liquid chromatography method with chemiluminescence detection (CL-HPLC), for determining trace levels of MA and its metabolites in a single human hair sample, in which bis(2,4,6-trichlorophenyl)oxalate and hydrogen peroxide are the postcolumn reagents. After washing a single hair sample with water and methanol, it was cut into pieces, extracted with a mixed solution of methanol and hydrochloric acid for 1 h under ultra-sonication and allowed to stand at room temperature overnight. Then the organic phase was evaporated to dryness. To the residues, 0.1 mL of carbonate buffer and 0.1 mL of dansyl chloride solution were added and the solution was heated at 45 degrees C for 1 h. An aliquot of the reaction mixture was then subjected to HPLC. MA and AP were chemiluminogenically detected as their dansyl derivatives from a sample of only a single hair. The detection limit was about 2 pg in an injected volume (20 microliters), and about 20 pg in a single hair sample. This detection limit was smaller than that by the gas chromatography/mass spectrometry (selective ion monitoring) method. Our method was useful as a screening test for stimulant users.
Biomedical Chromatography | 1999
Nariaki Takayama; Seishi Tanaka; Ryoichi Kizu; Kazuichi Hayakawa
Black hairs that had been removed from a methamphetamine (MA) addict were treated with permanent wave, dye or decolorant liquids, and MA and amphetamine (AP) were quantified by a high-performance liquid chromatography/chemiluminescence detection method. The concentrations of MA and AP in the hair decreased significantly in all cases. Both MA and AP were stable in the permanent wave treatments, but not stable in the dye or decolorant treatments. As possible reasons for the decrease, the elution of MA and AP from hair in the permanent wave treatment, and the degradation of MA and AP in the dye or decolorant treatments might be considered. These results suggested that treatments of hair with permanent wave, dye or decolorant liquids interfered with determination of MA and AP in hair.
Biological & Pharmaceutical Bulletin | 1993
Kazuichi Hayakawa; Yasuko Miyoshi; Hiroaki Kurimoto; Yuko Matsushima; Nariaki Takayama; Seishi Tanaka; Motoichi Miyazaki
Biomedical Chromatography | 2003
Nariaki Takayama; Reiko Iio; Seishi Tanaka; Satoshi Chinaka; Kazuichi Hayakawa
Analytical Sciences | 2001
Satoshi Chinaka; Seishi Tanaka; Nariaki Takayama; Naoko Tsuji; Shinya Takou; Kazumasa Ueda
Biomedical Chromatography | 2002
Seishi Tanaka; Reiko Iio; Satoshi Chinaka; Nariaki Takayama; Kazuichi Hayakawa
Biomedical Chromatography | 2001
Seishi Tanaka; Reiko Iio; Satoshi Chinaka; Nariaki Takayama; Kazuichi Hayakawa
Japanese journal of toxicology and environmental health | 1998
Nariaki Takayama; Seishi Tanaka; Ryoichi Kizu; Kazuichi Hayakawa